HK1161082A1 - Methods for treating reperfusion injuries - Google Patents
Methods for treating reperfusion injuriesInfo
- Publication number
- HK1161082A1 HK1161082A1 HK12101453.4A HK12101453A HK1161082A1 HK 1161082 A1 HK1161082 A1 HK 1161082A1 HK 12101453 A HK12101453 A HK 12101453A HK 1161082 A1 HK1161082 A1 HK 1161082A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- reperfusion injuries
- treating reperfusion
- treating
- injuries
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8576608P | 2008-08-01 | 2008-08-01 | |
PCT/US2009/052493 WO2010014957A1 (fr) | 2008-08-01 | 2009-07-31 | Procédés pour traiter des blessures de reperfusion |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1161082A1 true HK1161082A1 (en) | 2012-08-24 |
Family
ID=41610763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12101453.4A HK1161082A1 (en) | 2008-08-01 | 2012-02-15 | Methods for treating reperfusion injuries |
Country Status (11)
Country | Link |
---|---|
US (4) | US8324163B2 (fr) |
EP (1) | EP2320948B1 (fr) |
JP (1) | JP5577337B2 (fr) |
CN (1) | CN102170911B (fr) |
AU (1) | AU2009276357B2 (fr) |
CA (1) | CA2732763A1 (fr) |
EA (1) | EA020579B1 (fr) |
ES (1) | ES2412237T3 (fr) |
HK (1) | HK1161082A1 (fr) |
PT (1) | PT2320948E (fr) |
WO (1) | WO2010014957A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006069198A1 (fr) | 2004-12-22 | 2006-06-29 | Cleveland Clinic Foundation | Polypeptides associes a la flagelline et utilisations de ceux-ci |
CN102170911B (zh) | 2008-08-01 | 2014-07-02 | 克里夫兰生物实验室公司 | 用于治疗再灌注损伤的方法 |
SG191830A1 (en) | 2011-01-10 | 2013-08-30 | Cleveland Biolabs Inc | Use of toll-like receptor agonist for treating cancer |
WO2013082458A1 (fr) | 2011-12-02 | 2013-06-06 | The Regents Of The University Of California | Solution de protection de reperfusion et ses utilisations |
EP2833876A4 (fr) * | 2012-04-02 | 2015-09-09 | Health Research Inc | Compositions et procédés comprenant un récepteur de type toll (tlr) stimulant des agents pour la prophylaxie et la thérapie d'une lésion au niveau de l'épithélium dermique |
MX2017001279A (es) * | 2014-07-30 | 2017-08-07 | Cleveland Biolabs Inc | Usos y composiciones de la flagelina. |
US10183056B2 (en) | 2014-10-16 | 2019-01-22 | Cleveland Biolabs, Inc. | Methods and compositions for the treatment of radiation-related disorders |
CN109937045A (zh) * | 2016-08-11 | 2019-06-25 | 天普大学-联邦高等教育系统 | 局部缺血/再灌注损伤 |
AU2018304469B2 (en) | 2017-07-20 | 2023-04-06 | Spogen Biotech Inc. | Bioactive polypeptides for improvements in plant protection, growth and productivity |
CN208752357U (zh) * | 2018-09-21 | 2019-04-16 | 合肥京东方显示光源有限公司 | 背光模块及具有该背光模块的显示面板及显示器 |
KR102524577B1 (ko) | 2019-04-22 | 2023-04-21 | 전남대학교산학협력단 | 플라젤린 융합 단백질 및 이의 용도 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US5399494A (en) | 1983-03-04 | 1995-03-21 | The University Of Maryland System | Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom |
US6130082A (en) | 1988-05-05 | 2000-10-10 | American Cyanamid Company | Recombinant flagellin vaccines |
EP0503012B1 (fr) | 1990-09-28 | 1996-06-26 | Sulzer Innotec Ag | Canule pour utilisation medicale et procede pour la fabrication de telles canules |
EP0967279B1 (fr) | 1992-03-02 | 2008-01-02 | Novartis Vaccines and Diagnostics S.r.l. | Cytotoxine d' Helicobacter pylori utile dans des vaccins et en diagnostique |
US5693476A (en) | 1995-02-24 | 1997-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of screening for compounds capable of modulating vesicular release |
US20020009747A1 (en) | 1997-08-25 | 2002-01-24 | Freda Diane Miller | Methods and reagents for identifying modulators of neuronal apoptosis |
US5994409A (en) | 1997-12-09 | 1999-11-30 | U.S. Bioscience, Inc. | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds |
WO2001040280A2 (fr) | 1999-11-29 | 2001-06-07 | Inotek Corporation | Composition et procede destines a traiter une infection microbienne |
IL150885A0 (en) | 2000-01-31 | 2003-02-12 | Munin Corp | Cyr61 compositions and methods |
US7300749B2 (en) | 2000-02-17 | 2007-11-27 | Millennium Pharmaceuticals, Inc. | Molecules of the pyrin domain protein family and uses thereof |
AU2002216500A1 (en) | 2000-11-28 | 2002-06-11 | Genesis Research And Development Corporation Limited | Methods for modulating apoptotic cell death |
US8703146B2 (en) | 2001-04-20 | 2014-04-22 | Institute For Systems Biology | Toll-like receptor 5 ligands and methods of use |
WO2002085933A1 (fr) | 2001-04-20 | 2002-10-31 | The Institute For Systems Biology | Ligands de recepteur de type 5 et procedes d'utilisation |
EP1453467A4 (fr) | 2001-10-02 | 2008-01-09 | Univ Chicago | Procedes et compositions de modulation d'apoptose |
US7078165B2 (en) | 2003-03-27 | 2006-07-18 | Institut Pasteur | Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
WO2005056054A2 (fr) | 2003-12-02 | 2005-06-23 | Cleveland Clinic Foundation | Procedes pour inhiber une apoptose au moyen d'inducteurs de nf-$g(k)b |
SG148215A1 (en) * | 2003-12-02 | 2008-12-31 | Cleveland Clinic Foundation | Methods of protecting against radiation using flagellin |
WO2005056041A2 (fr) | 2003-12-02 | 2005-06-23 | Cleveland Clinic Foundation | Methodes d'inhibition apoptotique au moyen de tgf$g(b) latent |
US7638485B2 (en) * | 2003-12-02 | 2009-12-29 | Cleveland Biolabs, Inc. | Modulating apoptosis |
US20050266391A1 (en) * | 2004-01-15 | 2005-12-01 | Bennett Brydon L | Methods for preserving tissue |
WO2006066214A2 (fr) | 2004-12-16 | 2006-06-22 | Wake Forest University Health Sciences | Utilisation de la flagelline dans l'immunotherapie de yersinia pestis |
WO2006069198A1 (fr) * | 2004-12-22 | 2006-06-29 | Cleveland Clinic Foundation | Polypeptides associes a la flagelline et utilisations de ceux-ci |
US20090306190A1 (en) * | 2005-09-09 | 2009-12-10 | Mary Stenzel-Poore | Neuroprotectants |
WO2007070623A2 (fr) | 2005-12-14 | 2007-06-21 | Medistem Laboratories, Inc. | Immuno-embolisation de tumeurs par catheter |
AU2007239095B2 (en) | 2006-01-09 | 2012-05-03 | The Regents Of The University Of California | Immunostimulatory combinations for vaccine adjuvants |
EP2114427B1 (fr) | 2007-01-30 | 2014-06-25 | New York University | Peptides destinés à être utilisés dans un traitement d'états associés à de l'oxyde nitrique |
TR201000668T1 (tr) | 2007-07-31 | 2010-06-21 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Neoplasti̇k veya enfeksi̇yoz bozukluklara yöneli̇k i̇mmunoprofi̇laksi̇ veya i̇mmünoterapi̇ i̇çi̇n poli̇pepti̇d-nüklei̇k asi̇t konjugati |
EP2224954B1 (fr) | 2007-11-07 | 2014-01-08 | Celldex Therapeutics, Inc. | Anticorps qui se lient à la cellule dendritique et épithéliale 205 (dec-205) humaine |
WO2009102818A1 (fr) | 2008-02-11 | 2009-08-20 | Cleveland Biolabs, Inc. | Procédé de réduction des effets de la chimiothérapie à l’aide de polypeptides associés à la flagelline |
CN102170911B (zh) * | 2008-08-01 | 2014-07-02 | 克里夫兰生物实验室公司 | 用于治疗再灌注损伤的方法 |
EA021842B1 (ru) | 2009-10-06 | 2015-09-30 | Общество С Ограниченной Ответственностью "Панацела Лабс" | Применение toll-подобного рецептора и агониста для лечения рака |
-
2009
- 2009-07-31 CN CN200980138907.1A patent/CN102170911B/zh not_active Expired - Fee Related
- 2009-07-31 JP JP2011521369A patent/JP5577337B2/ja not_active Expired - Fee Related
- 2009-07-31 WO PCT/US2009/052493 patent/WO2010014957A1/fr active Application Filing
- 2009-07-31 AU AU2009276357A patent/AU2009276357B2/en not_active Ceased
- 2009-07-31 US US13/056,973 patent/US8324163B2/en not_active Expired - Fee Related
- 2009-07-31 CA CA 2732763 patent/CA2732763A1/fr not_active Abandoned
- 2009-07-31 EP EP20090803688 patent/EP2320948B1/fr not_active Not-in-force
- 2009-07-31 ES ES09803688T patent/ES2412237T3/es active Active
- 2009-07-31 EA EA201170294A patent/EA020579B1/ru not_active IP Right Cessation
- 2009-07-31 PT PT98036882T patent/PT2320948E/pt unknown
-
2012
- 2012-02-15 HK HK12101453.4A patent/HK1161082A1/xx not_active IP Right Cessation
- 2012-06-22 US US13/530,580 patent/US8618059B2/en not_active Expired - Fee Related
-
2013
- 2013-11-22 US US14/088,097 patent/US9006180B2/en not_active Expired - Fee Related
-
2015
- 2015-03-11 US US14/645,212 patent/US20150182587A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP5577337B2 (ja) | 2014-08-20 |
AU2009276357B2 (en) | 2014-09-11 |
EP2320948A4 (fr) | 2012-01-25 |
CN102170911A (zh) | 2011-08-31 |
US8324163B2 (en) | 2012-12-04 |
ES2412237T3 (es) | 2013-07-10 |
JP2011529922A (ja) | 2011-12-15 |
EA020579B1 (ru) | 2014-12-30 |
PT2320948E (pt) | 2013-06-17 |
US20110135665A1 (en) | 2011-06-09 |
EP2320948A1 (fr) | 2011-05-18 |
CA2732763A1 (fr) | 2010-02-04 |
US20140220037A1 (en) | 2014-08-07 |
US8618059B2 (en) | 2013-12-31 |
EP2320948B1 (fr) | 2013-03-06 |
US20150182587A1 (en) | 2015-07-02 |
EA201170294A1 (ru) | 2011-08-30 |
US9006180B2 (en) | 2015-04-14 |
WO2010014957A1 (fr) | 2010-02-04 |
CN102170911B (zh) | 2014-07-02 |
AU2009276357A1 (en) | 2010-02-04 |
US20130004515A1 (en) | 2013-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL257418A (en) | Methods for treating addiction | |
HK1161082A1 (en) | Methods for treating reperfusion injuries | |
IL212348A0 (en) | Treatment method | |
HK1167082A1 (en) | Compositions and methods for treating ischemia and ischemia reperfusion injury | |
IL209895A0 (en) | Compounds for treating beta-amyloidoses | |
LT2349132T (lt) | Aparatas gerl gydymui | |
PT2248083T (pt) | Método de autenticação | |
IL213619A0 (en) | Treatment | |
GB0802116D0 (en) | Treatment | |
EP2282826A4 (fr) | Procédés de traitement d'odeurs | |
IL211774A (en) | Animal Care Device | |
HK1203516A1 (en) | Methods for treating psoriasis | |
GB0822011D0 (en) | Treatment | |
EP2311711A4 (fr) | Appareil de direction | |
EP2341936A4 (fr) | PROCÉDÉS POUR LE TRAITEMENT OU LA PRÉVENTION DES MALADIES ASSOCIÉES À IL-1ß | |
GB0801209D0 (en) | Process | |
EP2453896A4 (fr) | Méthodes de traitement de la schizophrénie | |
GB0801580D0 (en) | Process | |
GB0811992D0 (en) | Treatment | |
GB0800875D0 (en) | Process | |
EP2296461A4 (fr) | Procédés de traitement d'arthropodes | |
EP2292495A4 (fr) | Appareil de direction | |
GB0820972D0 (en) | Treatment | |
IL213287A0 (en) | Treatment for glomerulonephritis | |
GB0805912D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180731 |